Item 1.01. Entry into a Material Definitive Agreement.

Merger Agreement

On July 12, 2022, Sharps Compliance Corp., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Raven Buyer, Inc., a Delaware corporation ("Parent"), and Raven Houston Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which, among other things, subject to the terms and conditions of the Merger Agreement, Merger Sub has agreed, and Parent has agreed to cause Merger Sub, to make a cash tender offer (the "Offer") to purchase all of the outstanding shares of common stock of the Company, $0.01 par value per share (the "Shares"), at a purchase price per Share of $8.75 in cash (the "Offer Price"), without interest, and subject to any required withholding of taxes. Parent and Merger Sub are affiliates of Aurora Capital Partners.

The Board of Directors of the Company determined that the transactions contemplated by the Merger Agreement, including the Offer and the Merger (as defined below), are fair to and in the best interests of the Company's stockholders, and unanimously approved the Merger Agreement and the transactions contemplated thereby, and recommended that the stockholders of the Company accept the Offer and tender their Shares pursuant to the Offer.

Unless the Offer is extended in accordance with the terms of the Merger Agreement, the Offer will expire one (1) minute following 11:59 p.m., New York City time, on the date that is twenty (20) business days after the commencement of the Offer. In the event that any of the conditions to the Offer are not satisfied or waived as of the scheduled expiration of the Offer, then Merger Sub is required to extend the Offer on one or more occasions in consecutive increments, for an additional period of up to ten (10) business days per extension to permit such Offer conditions to be satisfied (or waived by Parent and Merger Sub to the extent permitted under the terms of the Merger Agreement). If as of any scheduled expiration of the Offer, all of the conditions to the Offer, except for the Minimum Condition (as defined below), are satisfied or have been waived, then Merger Sub is only required to extend the Offer and its expiration date beyond the date of such scheduled expiration for one additional period not to exceed an aggregate of ten (10) business days to permit the Minimum Condition to be satisfied. Merger Sub is not required to extend the Offer beyond a date later than November 12, 2022.

The obligation of Merger Sub to purchase Shares tendered in the Offer is subject to certain closing conditions, including, (i) the expiration or termination of any waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), (ii) there having been validly tendered and not withdrawn the number of Shares that, together with the Shares, if any, then owned by Parent or any of its subsidiaries, would represent at least one Share more than fifty percent (50%) of the number of Shares that are then issued and outstanding (determined on a fully-diluted basis) (the "Minimum Condition"), (iii) the accuracy of the Company's representations and warranties contained in the Merger Agreement (subject, in certain cases, to Material Adverse Effect (as defined in the Merger Agreement) and materiality qualifiers), (iv) the Company's performance of or compliance with its obligations, covenants and agreements under the Merger Agreement in all material respects, and (v) the absence, since the date of the Merger Agreement, of any event that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect.

As soon as practicable after the consummation of the Offer and the satisfaction or waiver of certain conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company (the "Merger"), pursuant to Section 251(h) of the Delaware General Corporation Law ("DGCL"), with the Company being the surviving corporation (the "Surviving Corporation"). In the Merger, each Share that is not tendered and irrevocably accepted pursuant to the Offer will be cancelled and converted into the right to receive cash in an amount equal to the Offer Price, without interest (the "Merger Consideration") and subject to any required withholding of taxes, other than Shares (i) held in the treasury of the Company, (ii) owned directly or indirectly by Parent or Merger Sub immediately prior to the effective time of the Merger (the "Effective Time"), or (iii) held by stockholders

--------------------------------------------------------------------------------

who have properly exercised their appraisal rights under Delaware law. The consummation of the Merger is also subject to certain customary closing conditions, including that Merger Sub shall have irrevocably accepted for payment all Shares validly tendered (and not withdrawn) pursuant to the Offer.

Neither the Offer nor the Merger is subject to a financing condition.

At the Effective Time, each Company stock option granted under any Company stock plan, whether vested or unvested or exercisable, that is outstanding immediately prior to the Effective Time will be cancelled and, in exchange therefor, the Surviving Corporation will pay to each former holder of any such cancelled Company stock option as soon as practicable following the Effective Time an amount in cash (without interest, and subject to deduction for any required withholding tax) equal to the product of (i) the excess of the Merger Consideration over the applicable exercise price per Share under such Company stock option and (ii) the number of Shares subject to such Company stock option; provided, that if the exercise price per Share of any such Company stock option is equal to or greater than the Merger Consideration, such Company stock option will be cancelled without any cash payment being made in respect thereof.

At the Effective Time, each restricted stock award granted under any Company stock plan, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be cancelled and, in exchange therefor, will be converted automatically into and will thereafter represent the right to receive the Merger Consideration with respect to each Share subject to the cancelled Company restricted stock award.

The Company has agreed to customary covenants to conduct the business of the Company and its subsidiaries in the ordinary course of business consistent with past custom and practice until the Effective Time or the date that the Merger Agreement is terminated in accordance with its terms. The Company has, among other things, also agreed not to (i) solicit, initiate, endorse, or knowingly encourage or knowingly facilitate any inquiry, proposal, or offer with respect to, or the making or completion of, any third party Acquisition Proposal (as defined in the Merger Agreement), or any proposal or offer that is reasonably likely to lead to any third party Acquisition Proposal, (ii) enter into, continue, or otherwise participate in any discussions or negotiations regarding, or furnish to any person any information or data with respect to, or otherwise cooperate in any way with, any third party Acquisition Proposal, or (iii) . . .

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year

On July 11, 2022, the Board of Directors of the Company amended the Amended and Restated Bylaws of the Company (the "Bylaws"), effective immediately upon such approval.

The Bylaws were amended by adding new Article 14, "Forum for Adjudication of Disputes" that requires that, unless the Company, in writing, selects or consents to the selection of an alternative forum, the sole and exclusive forum for any current or former stockholder (including any current or former beneficial owner) to bring internal corporate claims (as defined below), to the fullest extent permitted by law, and subject to applicable jurisdictional requirements, shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court or a federal court located within the State of Delaware). To the fullest extent permitted by law, any person or entity purchasing or otherwise acquiring or holding any interest in shares of stock of the Company shall be deemed to have notice of and consented to the provisions of such article. For purposes of Article 14, "Forum for Adjudication of Disputes", internal corporate claims means: (i) any derivative action or proceeding brought on behalf of the Company; (ii) any action asserting a claim of breach of fiduciary duty owed by any current or former director, officer, employee, or stockholder of the Company to the Company or the Company's stockholders; (iii) any action asserting a claim arising pursuant to any provision of the DGCL, the Certificate of Incorporation of the Company, or the Bylaws (as either may be amended or restated) or as to which the DGCL confers jurisdiction upon the Court of Chancery of the State of Delaware; or (iv) any action asserting a claim governed by the internal affairs doctrine of the law of the State of Delaware.

The foregoing description of the amendment to the Bylaws does not purport to be complete is qualified in all respects by reference to the full text of the Bylaws, as amended to reflect the change described above, a copy of which is attached as Exhibit 3.1 to this Current Report on Form 8-K, which is incorporated into this Item 5.03 by reference.

Item 8.01. Other Events.

On July 12, 2022, the Company issued a press release announcing the entry into the Merger Agreement, a copy of which is filed as Exhibit 99.1 hereto and incorporated herein by reference.

Notice to Investors

--------------------------------------------------------------------------------

This Current Report on Form 8-K is being filed in accordance with the requirements of the Exchange Act and is neither a recommendation, an offer to purchase nor a solicitation of an offer to sell any shares of common stock of the Company or any other security, nor is it a substitute for the tender offer materials that Parent and Merger Sub will file with the SEC upon commencement of the Offer. The tender offer for the outstanding common stock of the Company referred to in this Current Report on Form 8-K has not yet commenced. Any offers to purchase or solicitation of offers to sell will be made only pursuant to the tender offer statement on Schedule TO (including an offer to purchase, a related letter of transmittal, and other documents relating to the Offer) which will be filed by Merger Sub with the SEC, and soon thereafter the Company will file a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the Offer. The Company's stockholders are urged to read carefully and in their entirety these documents and any other documents relating to the Offer that will be filed with the SEC because they will contain important information, including the various terms of, and conditions to, the tender offer, that the Company's stockholders should consider before making any decision regarding tendering their Shares. The offer to purchase, the related letter of transmittal, and certain other tender offer documents, as well as the Solicitation/Recommendation Statement on Schedule 14D-9, will be made available to all stockholders of the Company at no expense to them. The Company's stockholders may obtain free copies of these documents (when available), and other documents filed with the SEC, including annual, quarterly and special reports and other information filed by the Company with the SEC, at the SEC's website at www.sec.gov or by contacting the Company, 9220 Kirby Drive, Suite 500, Houston, Texas 77054; 713-432-0300, or by directing such requests to the Information Agent for the Offer, which will be named in the tender offer statement.

Forward-Looking Statements

The information in this Current Report on Form 8-K contains forward-looking statements relating to the Offer and Merger, and other statements about Parent, Merger Sub and the Company that are based on current beliefs, expectations and assumptions made by, and information currently available to, the Company's management on the date of this Current Report on Form 8-K. When used in this Current Report on Form 8-K, the words "may," "could," "potential," "anticipate," "believe," "expect," "estimate," and "intend" and words or phrases of similar import, as they relate to the Offer or the Company, are intended to identify forward-looking statements. Such statements reflect known and unknown risks, uncertainties, and assumptions related to certain factors, including, without limitation, changes in facts and circumstances and other risks, uncertainties and assumptions concerning the Offer and the subsequent Merger, including whether the Offer and the subsequent Merger will close; the timing of the closing of the Offer and subsequent Merger; strategic and other potential benefits of the transactions; the ability of the parties to satisfy the various conditions to the consummation of the Offer or the subsequent Merger, including the outcome of the regulatory reviews of the transactions and obtaining HSR approval, the percentage of outstanding shares that will be tendered in the Offer, the ability of the parties to complete the transactions; the ability of the parties to meet other closing conditions; the potential effects of the transactions; the outcome of legal proceedings (if any) that may be instituted against Parent, Merger Sub, the Company and/or others related to the transactions; unexpected costs or unexpected liabilities that may result from the transactions, whether or not consummated; the possibility that competing offers will be made; the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement, including in circumstances which would require the Company to pay a termination fee or other expenses; effects of disruption from the announcement or pendency of the transactions making it more difficult to maintain relationships with employees, customers, suppliers, and other business partners; risks related to diverting management's attention from the Company's ongoing business operations, and other general risks facing the Company's business and operations, including with respect to regulatory submissions, competitive factors, general economic conditions, customer relations, relationships with vendors, governmental regulation and supervision, seasonality, distribution networks, product introductions and acceptance, technological change, changes in industry practices, onetime events and other factors described herein including the impact of the coronavirus COVID-19 pandemic on the Company's operations and financial results; and those risks factors and other cautionary statements in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the SEC. The Company may update risk factors from time to time in Quarterly Reports on Form 10-Q, in Current Reports on Form 8-K, or in other filings with the SEC, available on the SEC's website at www.sec.gov.

--------------------------------------------------------------------------------

Based upon changing conditions, should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, or intended. Consequently, no forward-looking statements can be guaranteed. Actual results may vary materially. Do not place undue reliance on any forward-looking statements. Understand that it is not possible to predict or identify all such factors and as such do not consider the preceding list or the risk factors to be a complete list of all potential risks and uncertainties. All such forward-looking statements speak only as of the date they are made. None of the Company, Parent, Merger Sub or any affiliates thereof undertakes any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, subsequent events or circumstances, or otherwise, except as may be required by any applicable securities laws.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits
        Exhibit                                        Description
        Number
         2.1*             Agreement and Plan of Merger, dated as of July 12, 2022, by and among
                        Raven Buyer, Inc., Raven Houston Merger Sub, Inc., and Sharps Compliance
                        Corp.
          3.1             Amend    ment to     Amended and Restated Bylaws of Sharps Compliance
                        Corp., effective July     11    , 2022
         10.1             Tender and Support Agreement, dated as of     July     12    ,
                        2022    , by and among Raven Buyer, Inc., Raven Houston Merger Sub, Inc.,
                        and certain directors and executive officers of Sharps Compliance Corp.
         99.1             Press Release, dated as of     July     12    , 2022
         104.0          Cover Page Interactive Data File (embedded within the Inline XBRL
                        document)


* Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the Securities and Exchange Commission or its staff.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses